239.08 USD
↗ 7.79 (3.37%)AT CLOSE (11:59 AM EDT)
Johnson & Johnson
JNJNYSE • USD
238.25
↘ 0.83 (0.35%)
POST MARKET (AS OF 04:46 PM EDT)
Post Market
AS OF 04:46 PM EDT
238.25
↘ 0.83 (0.35%)
Market: OPEN
Johnson & Johnson (JNJ) trades at $238.25 per share. The technical outlook is "Buy" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, exceptional Return on Equity (25.9%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, JNJ trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 22, 2026.
Open?$235.64
High?$239.80
Low?$234.35
Prev. Close?$231.29
Volume?11.8M
Avg. Volume?8.1M
VWAP?$237.20
Rel. Volume?1.45x
Bid / Ask
Bid?$237.95 × 100
Ask?$240.00 × 100
Spread?$2.05
Midpoint?$238.98
Valuation & Ratios
Market Cap?556.8B
Shares Out?2.4B
Float?2.4B
Float %?100.0%
P/E Ratio?26.46
P/B Ratio?6.86
EPS?$8.74
Dividend?2.25%
Ex-Dividend?N/A
News
Profile
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Themes
Employees
140.8K
Market Cap
549.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1944-09-25
Address
ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?98
Momentum?31
Short Sent.?64
Piotroski F-Score?3/9Weak
Altman Z-Score?4.88Safe
Confidence?60%Moderate
Short InterestLow
Short % of Float?0.97%Low
Short Interest?23.4M
Days to Cover?3.0
Free Float2.4B
Avg Daily Volume7.9M
Settlement Date2026-05-29
Financial Health
Current Ratio?1.03Adequate
Quick Ratio?0.77Weak
Cash Ratio?0.38Low
Debt/Equity?0.68Moderate
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score61/100
P/E?26.5FAIR▾
Peers56
S&P44
P/B?6.86FAIR▾
Peers33
S&P27
P/S?5.78FAIR▾
Peers45
S&P24
P/FCF?32.0FAIR▾
Peers38
S&P26
EV/EBITDA?17.7FAIR▾
Peers50
S&P35
EV/Sales?6.12HIGH▾
Peers45
S&P27
Returns & Efficiency
ROE?25.9%STRONG▾
Peers67
S&P75
ROA?10.5%STRONG▾
Peers78
S&P76
Cash Flow & Enterprise
FCF?$17.4B
Enterprise Value?$590.1B
Fundamentals ratios updated end of day